CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 19 enrolled
Drug / intervention
stereotactic body radiotherapy (SBRT)radiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02919618
NCT02919618Phase 2Completed
CompareCT.gov

Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia

Washington University School of Medicine·interventional·Posted Sep 29, 2016·Updated Aug 21, 2024

In Brief

A Phase 2 clinical trial evaluating stereotactic body radiotherapy (SBRT) for Ventricular Tachycardia and 2 related conditions. Completed, enrolled 19 participants across 1 site.

Detailed Summary

Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation (ENCORE) for Treatment of Ventricular Tachycardia

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVentricular Tachycardia, Cardiomyopathy, Premature Ventricular Contractions
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedSep 29, 2016
Enrollment StartJul 1, 2016
Primary CompletionJul 23, 2018
Study CompletionJan 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 9.8 years ago

Interventions

stereotactic body radiotherapy (SBRT)radiation

(Cardiac ablative radiotherapy)